Literature DB >> 5109153

Vaso-obliteration and retrolental fibroplasia.

A Garner, N Ashton.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5109153      PMCID: PMC1812079     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN: 0035-9157


× No keyword cloud information.
  5 in total

1.  Pathological basis of retrolental fibroplasia.

Authors:  N ASHTON
Journal:  Br J Ophthalmol       Date:  1954-07       Impact factor: 4.638

2.  Role of oxygen in the genesis of retrolental fibroplasia; a preliminary report.

Authors:  N ASHTON; B WARD; G SERPELL
Journal:  Br J Ophthalmol       Date:  1953-09       Impact factor: 4.638

3.  Oxygen therapy in the newborn.

Authors:  N R Roberton; J M Gupta; G W Dahlenburg; J P Tizard
Journal:  Lancet       Date:  1968-06-22       Impact factor: 79.321

Review 4.  The effect of oxygen on immature retinal vessels.

Authors:  A Patz
Journal:  Invest Ophthalmol       Date:  1965-12

5.  Intermittent oxygen in retrolental fibroplasia.

Authors:  N Ashton; A Garner; G Knight
Journal:  Am J Ophthalmol       Date:  1971-01       Impact factor: 5.258

  5 in total
  3 in total

1.  Stimulating retinal blood vessel protection with hypoxia-inducible factor stabilization: identification of novel small-molecule hydrazones to inhibit hypoxia-inducible factor prolyl hydroxylase (an American Ophthalmological Society thesis).

Authors:  Jonathan E Sears; George Hoppe
Journal:  Trans Am Ophthalmol Soc       Date:  2013-09

2.  Nutrition, insulin-like growth factor-1 and retinopathy of prematurity.

Authors:  Anna-Lena Hård; Lois E Smith; Ann Hellström
Journal:  Semin Fetal Neonatal Med       Date:  2013-02-18       Impact factor: 3.926

Review 3.  Retinopathy of prematurity: inflammation, choroidal degeneration, and novel promising therapeutic strategies.

Authors:  José Carlos Rivera; Mari Holm; Dordi Austeng; Tora Sund Morken; Tianwei Ellen Zhou; Alexandra Beaudry-Richard; Estefania Marin Sierra; Olaf Dammann; Sylvain Chemtob
Journal:  J Neuroinflammation       Date:  2017-08-22       Impact factor: 8.322

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.